We are discussing ORIGIN3 and atacicept in IgAN.
APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻)
It's going to be Wicked good. 🧙♀️ #NephJC
Summary by @notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36
Join us tonight! #NephJC
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
Join us tonight! #NephJC
Kidney disease hasn’t stopped, so I won’t either. Join me and help me reach my goal for kidney patients. #KidneyWalk #kidneywalk2025
www.kidneywalk.org/dallas/DrTor...
Kidney disease hasn’t stopped, so I won’t either. Join me and help me reach my goal for kidney patients. #KidneyWalk #kidneywalk2025
www.kidneywalk.org/dallas/DrTor...
Every dollar you raise or donate brings us one step closer to our shared purpose.
Lace Up with me to help change lives. #KidneyWalk
Help me reach my goal!!
www.kidneywalk.org/dallas/DrTor...
Every dollar you raise or donate brings us one step closer to our shared purpose.
Lace Up with me to help change lives. #KidneyWalk
Help me reach my goal!!
www.kidneywalk.org/dallas/DrTor...
#NephJC
Join use only on #Bluesky on 9/16/25 at 9pm EST.
We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky
www.nephjc.com/news/accaha2025-klno3
#NephJC
#NephJC
www.nephjc.com/news/2025/9/ahaacc-htnguide
#NephJC
Infographic by @nephroseeker.medsky.socia
But… theoretical reasons do not matter anymore since in this well done, large trial with absolutely no benefit of spironolactone in ESRD. Coupled with the risk of serious hyperkalemia, spironolactone should no longer be used for CV protection in ESRD. #NephJC
⚡ Additionally, aldosterone, via mineralocorticoid receptor activation, drives:
⬆️ Reactive oxygen species (ROS)
⬇️ Nitric oxide (NO)
⬆️ Pro-inflammatory cytokines
A perfect storm for vascular injury & CV risk in ESRD.
#NephJC
www.ahajournals.org/...
The million-dollar ❓are aldosterone levels actually high in ESRD patients?
✅ Yes.
📊 Kohagura et al: ↑ in hypertensive HD patients
📊 Dreschler et al: ↑ in diabetic HD patients, linked to ↑ mortality
📊 Hung et al: linked to ↑ mortality and first CV event (without volume overload)
#NephJC
The million-dollar ❓are aldosterone levels actually high in ESRD patients?
✅ Yes.
📊 Kohagura et al: ↑ in hypertensive HD patients
📊 Dreschler et al: ↑ in diabetic HD patients, linked to ↑ mortality
📊 Hung et al: linked to ↑ mortality and first CV event (without volume overload)
#NephJC
Join us!
We will discuss the use of spironolactone in patients on dialysis to prevent t cardiovascular outcomes and heart failure hospitalizations.
Invite your friends. #NephJC #NephSky
www.nephjc.com/news/achieve
Join us!
Do not miss this NKF Renal Roundtable with Dr. Saxena from UTSW❗
📆 Thursday, July 31st, 2025
⌚ 6pm
It is free!
Registration link in the comments ⬇️
Do not miss this NKF Renal Roundtable with Dr. Saxena from UTSW❗
📆 Thursday, July 31st, 2025
⌚ 6pm
It is free!
Registration link in the comments ⬇️
Have fun testing and refreshing your knowledge about hypertension 🤓📖
📌HTN remains the leading global contributor to reno cardiovascular death and disability.
📌Take this evidence-based quiz from ISN SoMe team members to assess your knowledge and improve patient care. Here’s the link for the quiz: theisn.outgrow.us/HTN_2025
Have fun testing and refreshing your knowledge about hypertension 🤓📖
🧑🤝🧑1.3 billion people live with HTN, but only 1 in 5 meet BP goals.
⚠️HTN silently drives stroke, heart & kidney failure—and 57% of global deaths.
Check this beautiful Infographic by @gabyneph.bsky.social
#ISNTweetorial #WorldHypertensionDay
Don’t miss this space and learn about hypertension from the experts @edgarvlermamd.bsky.social & @hswapnil.medsky.social !!
@edgarvlermamd.bsky.social @hswapnil.medsky.social @myadla.bsky.social @dilushiwijay.bsky.social @ferarceamare.bsky.social
🗓️ May 22
🕑 3:00 pm CEST
⏰ Set your alarm here: twitter.com/i/spaces/1jM...
Don’t miss this space and learn about hypertension from the experts @edgarvlermamd.bsky.social & @hswapnil.medsky.social !!